Emma E. Page
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Hepatitis C virus research 9
-
- HIV/AIDS drug development and treatment 2
- COVID-19 Clinical Research Studies 1
- HIV/AIDS Research and Interventions 1
- Co-authors
- Mark Richard Nelson (7 shared papers)Brian Gazzard (3 shared papers)Peter Kelleher (4 shared papers)Mark Raymond Nelson (3 shared papers)Thomas Martin (1 shared paper)Natasha K. Martin (1 shared paper)Matthew Hickman (1 shared paper)Peter T. Vickerman (1 shared paper)
- Journals
- Current Opinion in HIV and AIDS (2 papers)AIDS (2 papers)The Lancet HIV (1 paper)Clinical Medicine (1 paper)Molecular Therapy — Methods & Clinical Development (1 paper)
- Partner nations
- United KingdomGermanyAustria
In The Last Decade
Emma E. Page
18 papers receiving 479 citations
Peers
Comparison fields: 5 of 50
- Hepatology 296
- Virology 47
- Epidemiology 197
- Infectious Diseases 96
- Biological Psychiatry 7
Countries citing papers authored by Emma E. Page
This map shows the geographic impact of Emma E. Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma E. Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma E. Page more than expected).
Fields of papers citing papers by Emma E. Page
This network shows the impact of papers produced by Emma E. Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma E. Page. The network helps show where Emma E. Page may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma E. Page, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 147 | |
| 2 | 2013 | 53 | |
| 3 | 2011 | 44 | |
| 4 | 2014 | 36 | |
| 5 | 2010 | 34 | |
| 6 | 2011 | 30 | |
| 7 | 2023 | 23 | |
| 8 | 2016 | 21 | |
| 9 | 2020 | 20 | |
| 10 | 2012 | 18 | |
| 11 | 2011 | 14 | |
| 12 | 2024 | 13 | |
| 13 | 2015 | 10 | |
| 14 | 2021 | 8 | |
| 15 | 2024 | 6 | |
| 16 | 2010 | 5 | |
| 17 | 2015 | 3 | |
| 18 | T cell response in immunosuppressed redo-liver transplant recipients after COVID-19 infection and after first dose of vaccine against SARS-CoV-2 | 2021 | 1 |
About Emma E. Page
Emma E. Page is a scholar working on Hepatology, Infectious Diseases, Virology, Epidemiology and Obstetrics and Gynecology, having authored 18 papers that have together received 486 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (2 papers), Liver Disease Diagnosis and Treatment (2 papers), HIV/AIDS drug development and treatment (2 papers), HIV Research and Treatment (2 papers), COVID-19 Clinical Research Studies (1 paper), HIV/AIDS Research and Interventions (1 paper) and Sex work and related issues (1 paper). The work is most often cited by research in Hepatology (296 citations), Virology (47 citations), Epidemiology (197 citations), Infectious Diseases (96 citations) and Biological Psychiatry (7 citations). Emma E. Page has collaborated with scholars based in United Kingdom, Germany and Austria. Frequent co-authors include Mark Richard Nelson, Brian Gazzard, Peter Kelleher, Mark Raymond Nelson, Thomas Martin, Natasha K. Martin, Matthew Hickman, Peter T. Vickerman, Christoph Boesecke and Jürgen Kurt Rockstroh. Their work appears in journals such as Current Opinion in HIV and AIDS, AIDS, The Lancet HIV, Clinical Medicine and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.